On Monday, ONEOK, Inc. (NYSE:OKE)’s shares inclined 0.46% to $39.01.
ONEOK, Inc. (OKE) the company declared and paid three dividends, and in January 2015, raised the dividend 7 percent.
Shareholders approved the following proposals:
- Election of three directors to the ONE Gas Board of Directors each for a three-year term;
- Selection of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for 2015;
- Performance aims and approval of the company’s executive compensation plan on an advisory basis; and
- Advisory votes on executive compensation will be conducted on a yearly basis.
ONE Gas trades on the New York Stock Exchange under the symbol “OGS,” and is comprised of in the S&P MidCap 400 Index.
ONE Gas provides natural gas distribution services to more than 2 million customers in Oklahoma, Kansas and Texas. ONE Gas is one of the largest publicly traded, 100 percent regulated, natural gas utilities in the United States.
ONE Gas, Inc. (OGS) is a natural gas distribution company and the successor to the company founded in 1906 as Oklahoma Natural Gas Company, which became ONEOK, Inc. (OKE) in 1980. On January 31, 2014, ONE Gas officially separated from ONEOK into a stand-alone, 100 percent regulated, publicly traded natural gas utility.
ONE Gas is headquartered in Tulsa, Okla., and its companies comprise the largest natural gas distributor in Oklahoma and Kansas, and the third largest in Texas, in terms of customers.
ONEOK, Inc. engages in the gathering, processing, storage, and transportation of natural gas in the United States. It operates in Natural Gas Gathering and Processing, Natural Gas Liquids, and Natural Gas Pipelines segments.
Heron Therapeutics Inc (NASDAQ:HRTX)’s shares gained 4.19% to $31.85.
Heron Therapeutics Inc (HRTX) declared closing of its underwritten public offering of 5,520,000 shares of common stock, counting 720,000 shares sold following the full exercise of an option to purchase additional shares formerly granted to the underwriters, at a public offering price of $24.75 per share. The gross offering size was about $136.6 million before deducting customary underwriting discounts and commissions and offering expenses.
Jefferies LLC, Leerink Partners LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. JMP Securities LLC, Brean Capital, LLC and Noble Life Science Partners acted as co-managers for the offering.
Heron Therapeutics, Inc. is a biotechnology company. The Company is using its proprietary technology to develop products to address unmet medical needs. Its Biochronomer polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by extending the duration of action of known active ingredients. Heron’s product candidate, SUSTOL (granisetron injection, extended release), is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting.
At the end of Monday’s trade, ING Groep NV (ADR) (NYSE:ING)‘s shares dipped -1.76% to $16.18.
ING Groep NV (ADR) (ING) declared the opening of a new office in Chicago, Illinois for its Acquisition Finance Group in the Americas (“AFG”). This adds to ING’s current U.S. office locations in New York, Atlanta, Dallas, Houston and Los Angeles. The Chicago office will bring the total number of employees in AFG to 23.
AFG is led by William Povey, ING’s Group Head of Acquisition Finance. The new Chicago office will focus on providing origination and underwriting of cash flow and asset-based loans in support of middle market leveraged buyouts and recapitalizations throughout the Midwest.
AFG is an active leveraged loan investor supporting the private equity community and remains a reliable and competitive source of capital throughout all economic cycles dating back over twenty-five years. AFG’s product suite comprises senior secured amortizing and bullet maturity term loans, revolving credit facilities, and through its associates, subordinated debt private placements and interest rate and foreign exchange derivatives.
ING Groep N.V., a financial institution, provides banking products and services to individuals, small and medium enterprises, and mid-corporates. It operates through Retail Netherlands; Retail Belgium; Retail Germany; Retail Rest of World; and Commercial Banking segments.
Frontline Ltd. (NYSE:FRO), ended its Monday’s trading session with -5.08% loss, and closed at $2.80.
Frontline (FRO) released its first quarter 2015 earnings results.
For the quarter, the company’s operating profit jumped to $39.5 million from $5.6 million a year earlier, beating expectations for $36 million, according to analysts polled by Thomson Reuters.
On a per share basis, Frontline posted earnings of 25 cents per share, beating the consensus estimate of 18 cents per share.
Frontline Ltd., a shipping company, through its auxiliaries, owns and operates oil tankers and oil/bulk/ore carriers. The company provides seaborne transportation of crude oil and oil products. It’s very large crude carriers (VLCCs) primarily transport crude oil from the Middle East Gulf to the Far East, Northern Europe, the Caribbean, and the Louisiana Offshore Oil Port, in addition to Suezmax tankers trade in the Atlantic Basin, the Middle East, and Southeast Asia. As of December 31, 2014, the company’s tanker fleet comprised of 22 vessels, counting 14 VLCCs and 8 Suezmax tankers. It is also involved in the charter, purchase, and sale of vessels.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.